🇺🇸 Burosumab Injection [Crysvita] in United States

Burosumab Injection [Crysvita] (Burosumab Injection [Crysvita]) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Burosumab Injection [Crysvita] in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Burosumab Injection [Crysvita] approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Burosumab Injection [Crysvita] in United States?

Yale University is the originator. The local marketing authorisation holder may differ — check the official source linked above.